PMID- 29416432
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20200929
IS  - 1428-2526 (Print)
IS  - 1897-4309 (Electronic)
IS  - 1428-2526 (Linking)
VI  - 21
IP  - 4
DP  - 2017
TI  - Radioembolization treatment for liver metastases.
PG  - 274-278
LID - 10.5114/wo.2017.72153 [doi]
AB  - The liver is an organ that, due to vascularisation and functions, is prone to 
      metastases. Most liver metastases are observed in cases of gastrointestinal 
      cancers in: stomach, colon, gallbladder, and bile ducts. Metastatic lesions are 
      also observed in lung, breast, thyroid, kidney, and pancreatic cancer. One of the 
      best known and most effective ways of liver lesion treatment is Metastasectomy. 
      Unfortunately, lesions are frequently inoperable. Apart from chemotherapy, it is 
      possible to apply local treatment such as TACE (trans-arterial 
      chemoembolisation), RFA (Radio Frequency Ablation), and SBRT (Stereotactic Body 
      Radiation Therapy). One of the newest methods of inoperable lesion treatment is 
      radioembolisation (SIRT). Intravascular administration of microspheres containing 
      radioisotope 90Y allows delivery of a higher dose of radiation directly to the 
      tumour than traditional radiation with an external beam, while maintaining a 
      small dose to healthy liver methods. Conducted clinical studies confirm the 
      efficacy and safety of SIRT. It is an interesting alternative to other ways of 
      treatment.
FAU - Kiszkaa, Joanna
AU  - Kiszkaa J
AD  - Subcarpatia Cancer Center in Rzeszow, Poland.
AD  - Department of Oncology, Faculty of Medicine, University of Rzeszow, Poland.
FAU - Karczmarek-Borowska, Bozenna
AU  - Karczmarek-Borowska B
AD  - Subcarpatia Cancer Center in Rzeszow, Poland.
AD  - Department of Oncology, Faculty of Medicine, University of Rzeszow, Poland.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20171230
PL  - Poland
TA  - Contemp Oncol (Pozn)
JT  - Contemporary oncology (Poznan, Poland)
JID - 101233223
PMC - PMC5798416
OTO - NOTNLM
OT  - hepatocellular carcinoma
OT  - liver metastases
OT  - radioembolisation
COIS- The authors declare no conflict of interest.
EDAT- 2018/02/09 06:00
MHDA- 2018/02/09 06:01
PMCR- 2017/01/01
CRDT- 2018/02/09 06:00
PHST- 2017/02/01 00:00 [received]
PHST- 2017/08/26 00:00 [accepted]
PHST- 2018/02/09 06:00 [entrez]
PHST- 2018/02/09 06:00 [pubmed]
PHST- 2018/02/09 06:01 [medline]
PHST- 2017/01/01 00:00 [pmc-release]
AID - 31255 [pii]
AID - 10.5114/wo.2017.72153 [doi]
PST - ppublish
SO  - Contemp Oncol (Pozn). 2017;21(4):274-278. doi: 10.5114/wo.2017.72153. Epub 2017 
      Dec 30.